论文部分内容阅读
目的:对二甲双胍治疗糖尿病的临床治疗效果进行观察。方法:选取从2012年7月~2013年8月收治的120位患有2型糖尿病的患者,随机的将所有患者分成治疗组与对照组,两组都有60位患者,对照组患者采用胰岛素进行治疗,治疗组患者在对照组患者治疗的基础上结合二甲双胍进行治疗。对两组患者的血糖指标进行观察。结果:在空腹的状态下,治疗组的60位患者中,有56位患者血糖符合标准,符合标准概率为93.33%,在对照组的60位患者中,有54位患者血糖符合标准,符合标准概率为90.00%;餐后两小时,治疗组的60位患者中,有47位患者血糖符合标准,符合标准概率为78.33%,在对照组的60位患者中,有42位患者血糖符合标准,符合标准概率为70.00%,将两组患者进行对比,P<0.05,两组之间的差异具有统计学的意义。结论:采用胰岛素对2型糖尿病患者进行治疗的过程中,患者不能有任何的禁忌症,在结合二甲双胍治疗以后,将血糖效果比较理想。
Objective: To observe the clinical effect of metformin in the treatment of diabetes mellitus. Methods: A total of 120 patients with type 2 diabetes mellitus who were admitted to our hospital from July 2012 to August 2013 were randomly divided into treatment group and control group. Both groups had 60 patients. The control group received insulin The patients in the treatment group were treated with metformin on the basis of the treatment in the control group. The two groups of patients were observed for glycemic index. Results: In the fasting state, the treatment group of 60 patients, 56 patients with blood glucose compliance standard, with a standard probability of 93.33%, 60 patients in the control group, 54 patients with blood glucose compliance standards, in line with the standard The probability of 90.00%; two hours after the meal, the treatment group of 60 patients, 47 patients with blood glucose compliance standard, the standard probability of 78.33%, 60 patients in the control group, 42 patients with blood glucose standards, Meet the standard probability of 70.00%, the two groups were compared, P <0.05, the difference between the two groups was statistically significant. Conclusion: Patients with type 2 diabetes treated with insulin should not have any contraindications. After treatment with metformin, their blood glucose will be more satisfactory.